-transparent.png){kind=logo}
Ivermectin for COVID-19: Promising but not yet conclusive. 2021
Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, Cape Town, South Africa. 22428585@sun.ac.za.
Related Publications
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
January 2023,
Nursing,
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
June 2006,
Expert review of pharmacoeconomics & outcomes research,
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
July 2019,
Lancet (London, England),
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
February 2011,
Surgical endoscopy,
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
December 2021,
Environmental microbiology,
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
March 2021,
Journal of the American College of Cardiology,
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
January 2021,
Inter economics,
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
November 2020,
Cleveland Clinic journal of medicine,
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
September 2021,
Science (New York, N.Y.),
R Van Rensburg, and
E H Decloedt, and
H Reuter, and
A Parker, and
N Schrueder, and
S Lahri
December 2022,
The New England journal of medicine,
